Patents matching “alzheimer”

US 10774121

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

The Regents of the University of California · Granted Sep 15, 2020 · Expires Sep 10, 2040

US 10603311

Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

The Board of Regents of the University of Texas System · Granted Mar 31, 2020 · Expires Mar 26, 2040

US 10457670

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers disease

Takeda Pharmaceutical Company Limited · Granted Oct 29, 2019 · Expires Oct 24, 2039

US 10233222

Methods, compositions, diagnostics and assays for the treatment of Alzheimer's disease

The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2019 · Expires Mar 14, 2039

US 10221223

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Mar 5, 2019 · Expires Feb 28, 2039

US 9868725

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Jan 16, 2018 · Expires Jan 11, 2038

WO 2017194692

DERIVES DE LA BENZOXAZINE OU DE LA QUINAZOLINE POUR LEUR UTILISATION DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

BIOCODEX [FR] · Granted Nov 16, 2017 · Expires Nov 11, 2037

US 9724339

Methods and drug products for treating alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Aug 8, 2017 · Expires Aug 3, 2037

US 9717710

Treatment of mild and moderate Alzheimer's disease

VTV THERAPEUTICS LLC · Granted Aug 1, 2017 · Expires Jul 27, 2037

US 9585558

Hyperspectral imaging for early detection of Alzheimer'S Disease

Regents of the University of Minnesota · Granted Mar 7, 2017 · Expires Mar 2, 2037

US 9517222

Method for the treatment of senile dementia of the Alzheimer's type

Phenomenome Discoveries Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9512191

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

US 9315534

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 19, 2016 · Expires Apr 14, 2036

US 9192644

Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders

The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

US 9102752

Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

United Biomedical, Inc. · Granted Aug 11, 2015 · Expires Aug 6, 2035

US 9102666

Methods and drug products for treating Alzheimer's disease

Takeda Pharmaceutical Company Limited · Granted Aug 11, 2015 · Expires Aug 6, 2035

US 9034923

Methods for the treatment of senile dementia of the alzheimer's type

Phenomenome Discoveries Inc. · Granted May 19, 2015 · Expires May 14, 2035

US 8951794

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Feb 10, 2015 · Expires Feb 5, 2035

US 8945858

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

US 8617549

Bispecific nanobodies as a therapeutic for alzheimer's disease

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 31, 2013 · Expires Dec 26, 2033

US 8394380

Compositions and methods for alzheimer's disease

Primex Clinical Laboratories, Inc. · Granted Mar 12, 2013 · Expires Mar 7, 2033

US 8389478

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

The Regents of the University of California · Granted Mar 5, 2013 · Expires Feb 28, 2033

US 8232373

Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

United Biomedical, Inc. · Granted Jul 31, 2012 · Expires Jul 26, 2032

US 8129334

Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory

The Regents of the University of California · Granted Mar 6, 2012 · Expires Mar 1, 2032